FDAnews Device Daily Bulletin

New England Journal of Medicine Publishes FAME II Trial Results Revealing Better Patient Outcomes With FFR-Guided Cardiac Stenting

Aug. 29, 2012
A A
St. Jude Medical, Inc., a global medical device company, today announced results of the FAME II Trial demonstrating that patients with FFR-guided stenting plus the best available medical therapy had superior outcomes to those treated with medical therapy alone.
heraldonline.com